The market for allogeneic stem cells is at the vanguard of regenerative medicine, offering tremendous promise for the treatment of a variety of diseases. During the period from 2023 to 2031, the allogeneic stem cell market is projected to expand at a CAGR of 6.5%, driven by advances in unmodified stem cell transplants, expanding applications in oncology, and emerging therapies ...
Read More »